Pellizzari Christine A — SEC insider filings
SEC reporting owner CIK 1127430. 37 insider filings on record with FilingPulse; latest filed 2026-11-10.
Transaction summary — filings shown
Covers all 37 filings on record, filed 2020-11-05 to 2026-11-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 5,000 shares, $4,032 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 19 legs across 4 filings — 218,946 shares, $7,942,969 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 90.
- Largest priced transaction: sale of 38,396 shares @ $32.95 ($1,265,148) in INSMED Inc, filed 2020-11-05.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| INSMED Inc (INSM) | Chief Legal Officer | 8 | — | 19 legs · 218,946 sh · $7,942,969 | 50 |
| Science 37 Holdings, Inc. (SNCE) | Chief Legal and HR Officer | 10 | 1 leg · 5,000 sh · $4,032 | — | 20 |
| Imunon, Inc. (IMNN) | Director | 13 | — | — | 14 |
| Tempest Therapeutics, Inc. (TPST) | Director | 6 | — | — | 6 |
Insider filings — Pellizzari Christine A
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-10 | 4 | Imunon, Inc. (IMNN) | Grant/award (A): 13,166 @ $0.84 | EDGAR |
| 2026-08-04 | 4 | Imunon, Inc. (IMNN) | Grant/award (A): 6,934 @ $1.59 | EDGAR |
| 2026-05-27 | 4 | Imunon, Inc. (IMNN) | Grant/award (A): 5,557 @ $2.20 | EDGAR |
| 2026-01-28 | 4 | Tempest Therapeutics, Inc. (TPST) | Grant/award (A): 1,230 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Imunon, Inc. (IMNN) | Grant/award (A): 4,827 (derivative) @ $0 | EDGAR |
| 2025-08-06 | 4 | Imunon, Inc. (IMNN) | Grant/award (A): 2,248 @ $9.20 · Grant/award (A): 250 (derivative) @ $0 | EDGAR |
| 2025-03-18 | 4 | Imunon, Inc. (IMNN) | Grant/award (A): 3,750 (derivative) @ $0 | EDGAR |
| 2024-09-10 | 4 | Imunon, Inc. (IMNN) | Grant/award (A): 4,964 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | Tempest Therapeutics, Inc. (TPST) | Grant/award (A): 16,000 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | Imunon, Inc. (IMNN) | Grant/award (A): 4,500 (derivative) @ $0 | EDGAR |
| 2024-03-18 | 4 | Imunon, Inc. (IMNN) | Grant/award (A): 4,500 (derivative) @ $0 | EDGAR |
| 2024-03-12 | 4 | Science 37 Holdings, Inc. (SNCE) | Code (U): 14,579 @ $5.75 · Disposition to issuer (D): 35,115 @ $5.75 · Disposition to issuer (D): 37,222 (derivative) · Disposition to issuer (D): 428 (derivative) | EDGAR |
| 2023-08-15 | 4 | Science 37 Holdings, Inc. (SNCE) | Option exercise (M): 355,549 @ $0 · Tax withholding (F): 86,577 @ $0.44 · Option exercise (M): 355,549 (derivative) @ $0 | EDGAR |
| 2023-06-20 | 4 | Tempest Therapeutics, Inc. (TPST) | Grant/award (A): 8,200 (derivative) @ $0 | EDGAR |
| 2023-05-22 | 4 | Science 37 Holdings, Inc. (SNCE) | Option exercise (M): 16,667 @ $0 · Tax withholding (F): 5,614 @ $0 · Option exercise (M): 16,667 (derivative) @ $0 | EDGAR |
| 2023-05-02 | 4 | Science 37 Holdings, Inc. (SNCE) | Grant/award (A): 702,332 · Disposition to issuer (D): 1,270,739 (derivative) · Disposition to issuer (D): 238,095 (derivative) · Disposition to issuer (D): 247,000 (derivative) | EDGAR |
| 2023-03-21 | 4 | Imunon, Inc. (IMNN) | Grant/award (A): 2,000 (derivative) @ $0 | EDGAR |
| 2022-11-17 | 4 | Science 37 Holdings, Inc. (SNCE) | Purchase (P): 5,000 @ $0.81 | EDGAR |
| 2022-08-16 | 4 | Science 37 Holdings, Inc. (SNCE) | Grant/award (A): 1,066,646 (derivative) @ $0 | EDGAR |
| 2022-06-22 | 4 | Tempest Therapeutics, Inc. (TPST) | Grant/award (A): 3,500 (derivative) @ $0 | EDGAR |
| 2022-06-15 | 4 | Celsion CORP (CLSN) | Grant/award (A): 2,500 (derivative) @ $0 | EDGAR |
| 2022-05-24 | 4 | Science 37 Holdings, Inc. (SNCE) | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2022-03-07 | 4 | Celsion CORP (CLSN) | Grant/award (A): 2,500 (derivative) @ $0 | EDGAR |
| 2022-01-11 | 4 | Science 37 Holdings, Inc. (SNCE) | Grant/award (A): 238,095 (derivative) @ $0 | EDGAR |
| 2021-10-12 | 4 | Science 37 Holdings, Inc. (SNCE) | Grant/award (A): 8,541 (derivative) · Grant/award (A): 247,000 (derivative) @ $0 | EDGAR |
| 2021-10-08 | 4 | Science 37 Holdings, Inc. (SNCE) | Grant/award (A): 1,270,710 (derivative) | EDGAR |
| 2021-09-20 | 4/A | Tempest Therapeutics, Inc. (TPST) | Grant/award (A): 6,635 (derivative) @ $0 | EDGAR |
| 2021-07-06 | 4 | Tempest Therapeutics, Inc. (TPST) | Grant/award (A): 6,635 (derivative) | EDGAR |
| 2021-06-09 | 4 | Celsion CORP (CLSN) | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2021-05-18 | 4 | INSMED Inc (INSM) | Tax withholding (F): 2,546 @ $26.23 | EDGAR |
| 2021-05-14 | 4 | INSMED Inc (INSM) | Grant/award (A): 11,810 · Grant/award (A): 57,200 (derivative) @ $0 | EDGAR |
| 2021-02-10 | 4 | INSMED Inc (INSM) | Option exercise (M): 6,400 @ $10.85 · Sale (S): 6,400 @ $43.95 · Option exercise (M): 15,150 @ $10.85 · Sale (S): 15,150 @ $45 · Option exercise (M): 6,400 (derivative) @ $0 · Option exercise (M): 15,150 (derivative) @ $0 | EDGAR |
| 2021-01-27 | 4 | INSMED Inc (INSM) | Option exercise (M): 15,000 @ $10.85 · Sale (S): 15,000 @ $42.95 · Option exercise (M): 6,000 @ $10.85 · Sale (S): 6,000 @ $43.84 · Option exercise (M): 2,600 @ $10.85 · Sale (S): 2,600 @ $44.04 · +3 more | EDGAR |
| 2021-01-22 | 4 | INSMED Inc (INSM) | Option exercise (M): 10,000 @ $10.85 · Sale (S): 10,000 @ $39.87 · Option exercise (M): 10,000 @ $10.85 · Sale (S): 10,000 @ $41.05 · Option exercise (M): 10,000 @ $10.85 · Sale (S): 10,000 @ $41.98 · +3 more | EDGAR |
| 2021-01-08 | 4 | INSMED Inc (INSM) | Grant/award (A): 9,183 · Grant/award (A): 45,600 (derivative) @ $0 | EDGAR |
| 2021-01-06 | 4 | INSMED Inc (INSM) | Tax withholding (F): 1,814 @ $33.29 · Tax withholding (F): 650 @ $33.42 | EDGAR |
| 2020-11-05 | 4 | INSMED Inc (INSM) | Tax withholding (F): 1,575 @ $25.46 · Option exercise (M): 12,683 @ $11.14 · Sale (S): 12,683 @ $32.34 · Option exercise (M): 10,649 @ $11.14 · Sale (S): 10,649 @ $32.36 · Option exercise (M): 14,351 @ $11.14 · +32 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-11-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1127430 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs